During this period of COVID-19 lockdowns and increased alert levels, we hope this edition of the HealthTech Activator (HTA) Monthly Wrap finds you well.
This month we bring updates on planned events, an e-Learning course available for signup, an overview of valuation from Jai Basrur of CGB Consulting, and more - check out the links below for further details.
29 September 2021
Presented by Tim McCready of BioPacific Partners, this programme is tailored for the specific challenges of capital raising faced by healthtech companies.
We encourage those early to mid stage healthtech companies seeking to raise capital for the first time outside their immediate contacts to attend.
The Quality Management System (QMS) Primer is a wholly online, self-paced course providing an overview of quality management systems, their benefits and what you need to consider before implementation.
It is provided by Seerpharma and is supported and fully funded by the REDI initiative, powered by MTPConnect, so there is no cost to you for this programme.
Expressions of interest open for February 2022
As mentioned in our July Monthly Wrap, expressions of interest for healthtech companies to join the Feb 2022 In-Depth Market Validation cohort are now open. Contact the HTA Coordinator, Jamie Attenborough (email linked here), if you’re interested in the programme or would like further information.
Jai Basrur, CGB Consulting
To understand how to value a healthtech company it is first important to understand the nuances of valuation. In this article, Jai Basrur provides a comprehensive overview of valuation, from definition through to typically used valuation methods and considerations.
CRISPR Hits Home in a First-in-Human Study (abstract only)